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Oversight During Research
HRPO
– Continuing Review: Informed Consent and
Protocol Lapses
• Consent document can only be used through the date
of expiration to enroll new subjects.
– Must be renewed at least annually

• Protocol lapses occur when you allow a protocol to
expire prior to renewal
– No new participants may be enrolled.
– No continuation of treatment may take place without written
HRPO authorization
– No federal funds may be expended on human research if
protocol allowed to lapse

Top 3 Issues Around
Successful Research
Design
Inclusion/Exclusion Criteria
Testing/Observation Regimen

Consent Issues
Prior to Research
Obtained in HRPO approved manner

Record Keeping
Documentation of all encounters with subject

Research/Protocol Design
Inclusion/Exclusion Criteria
Each enrolled subject must meet
Enrollment of eligible subjects must be
documented

Interventions/Observations
Subjects must have all expected interventions or
observations performed and documented

Consent Issues
Expect to find one consent per subject having
data collected
Consent document must be appropriately
signed and witnessed
Consent must be obtained in manner
approved by HRPO
Children
Phone Consent
Legally Authorized Respresentative

Consent Form Issues
(continued)

Did the subject receive a copy of the
signed consent form?
As a good practice, if mailed, send 2 copies
& document. One comes back to you.
Participant keeps the other.
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Consent Form Issues

The latest version is not being used
•Check approval and expiration dates on
consent form
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Consent Form Issues
(continued)

Did the subject receive a copy of the signed
consent form?
•Document the fact that subject received a
signed copy of the consent form
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Consent Form Issues
(continued)

Did the subject date
the signed consent form?
Never backdate a consent form
•If subject failed to date the consent form,
write a note-to-file
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Consent Form Issues
(continued)

IRB approval stamp is not on the consent
form
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Consent Form Issues
(continued)

Hand written changes can not be made to an
approved consent form
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Record Keeping

Binder for regulatory documents

•An industry sponsored study will
require more regulatory documents
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TYPES OF STUDY LOGS
(NOT ALL ARE NEEDED FOR ALL STUDIES)

• Enrollment Log
• Staff Signature Log
• Delegation of Responsibility Log
• Monitoring Log
• Drug Dispensing/Accountability Log
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Drug Accountability/Dispensing Log
• Protocol identifier
• Subject identifiers (initials/study number)
• Randomization and/or kit number
• Date dispensed & amount dispensed
• Date returned & amount returned
•Initials of person dispensing/receiving
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Data and Safety Monitoring Board
(DSMB) Report
Failure to submit a copy of the DSMB
REPORT to the HRPO at continuing
review
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Investigator Brochure (IB)
Why is the IB not on file?
Reason #1:

It’s too big to keep in the
regulatory binder

Solution #1:

Write a signed and dated
note-to-file indicating where
it is located.
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Investigator Brochure
Why is the IB not on file?
Reason #2: We’re studying a marketed
drug.
Solution #2: Obtain a copy of the package
insert.
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Investigator Brochure
Why do I need a copy of the IB?
To provide safety and efficacy data from
pre-clinical and clinical trials to support
human exposure by the route, at the
dosages, for the duration, and in the
population to be studied.
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Source Documents
(Not submitted to IRB. Developed by study team or industry sponsor.)

Source documents include:
1.

hospital records

2.

lab notes

3.

memos

4.

subject diaries

5.

evaluation checklists

6.

pharmacy dispensing records
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Source Documents
(examples include)

7.

X-rays

8.

copies of transcriptions certified after verification as
being accurate and complete

9.

microfiches

10.

photographic negatives

11.

microfilm or magnetic media

12.

recorded data from automated instruments
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Source Documents

Q. Why are source documents needed?
A. To document the existence of the
subject and substantiate integrity of trial
data collected.
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Source Documents
Q.

What are source documents?

A.

It’s wherever data is first recorded
(original records or certified copies)
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Assistance for Successful Research

• Educational Programs
• Staff Training Program
• Research News
– http://researchnews.wustl.edu

Organizational Offices and Points of Contact
Available to Help
– Human Research Protection Office
• 314-633-7400; http://hrpo.wustl.edu

– Grants & Contracts
• 314-747-4134; http://grantsandcontracts.wustl.edu

– Research Office
• 314-935-5889; http://wuro.wustl.edu

– Sponsored Project Accounting
• 314-935-xxxx; http://spa.wustl.edu

– Center for Clinical Studies
• 314-747-4000; http://ccs.wustl.edu

